We are pleased to announce that our COO, Dr. Lesley Hill, will be showcasing Mesintel at Invest in the West, presented by Amplitude Ventures, on Thursday, March 10th! Join us to find out how we are harnessing the power of fibroblasts to treat disease.

Our website is now LIVE! Stop by to learn more! mesintel.com #fibroblasts

Mesintel is looking forward to attending this week's (April 20-21) Life Science WA conference. Stop by to see us! #LSINW2022

Congratulations to our CBO, Jonathon Jafari, for winning the fast pitch showdown at the Life Science WA Conference! #LSINW22 was a great opportunity to network and learn from industry leaders. Amazing job team 👏🏼!

Mesintel's CEO and CSO, Dr. Michael Underhill, will be presenting at #AACRsarcoma22. Tune in to learn about mesenchymal progenitors and sarcomagenesis!

Mesintel is thrilled to announce that we have been selected for a Fueling Biotechnology Partnership grant, supported by the Stem Cell Network, to investigate novel therapeutic strategies to promote liver regeneration!

Mesintel will be at #BIO2022, and we will be participating in the BIOTECanada Coast-to-Coast panel! Stop by to learn more!

Congratulations to our CBO, Jonathon Jafari, for winning the BIOTECanada Coast-to-Coast competition at BIO! #BIO2022

It’s #WomensHistoryMonth and we’re profiling inspiring women that have positively impacted #stemcell science. This week’s feature includes the women behind two of Canada’s #biotech start-ups - Dr. Hill Mesintel Therapeutics & Dr. Titus at Notch Therapeutics. stemcellnetwork.ca/wp-content/upl…

We are proud to announce that Mesintel has been accepted into the newly launched Creative Destruction Lab (Creative Destruction Lab (CDL)) Advanced Therapies stream, formed in partnership with CCRM (CCRM)! #CDL #CCRM #BuildSomethingMassive

Our CEO and CSO, Dr. T. Michael Underhill, will be presenting at the 6th Annual Antifibrotic Drug Development Summit! Tune into the discussion panel: “debating the commonalities & disparities between the different fibrotic disease indications & organ specific fibroses.”

We are thrilled to be presenting at the #OBIOInvestmentSummit, featuring Canada’s most investible health science companies commercializing products in regenerative medicine, stem cell therapy & more! + a big thank you to the Stem Cell Network for their support! #OBIO #OIS2023